Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL FRIEDREICH ATAXIA DRUG INDUSTRY
2.1 Summary about Friedreich Ataxia Drug Industry
2.2 Friedreich Ataxia Drug Market Trends
2.2.1 Friedreich Ataxia Drug Production & Consumption Trends
2.2.2 Friedreich Ataxia Drug Demand Structure Trends
2.3 Friedreich Ataxia Drug Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 ADVM-063
4.2.2 AGIL-FA
4.2.3 BHV-4157
4.2.4 BVA-202
4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Clinic
4.3.2 Hospital
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 ADVM-063
5.2.2 AGIL-FA
5.2.3 BHV-4157
5.2.4 BVA-202
5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Clinic
5.3.2 Hospital
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 ADVM-063
6.2.2 AGIL-FA
6.2.3 BHV-4157
6.2.4 BVA-202
6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Clinic
6.3.2 Hospital
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 ADVM-063
7.2.2 AGIL-FA
7.2.3 BHV-4157
7.2.4 BVA-202
7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Clinic
7.3.2 Hospital
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 ADVM-063
8.2.2 AGIL-FA
8.2.3 BHV-4157
8.2.4 BVA-202
8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Clinic
8.3.2 Hospital
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 ADVM-063
9.2.2 AGIL-FA
9.2.3 BHV-4157
9.2.4 BVA-202
9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Clinic
9.3.2 Hospital
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Adverum Biotechnologies Inc
10.1.2 BioMarin Pharmaceutical Inc.
10.1.3 Biovista Inc.
10.1.4 Cardero Therapeutics Inc
10.1.5 Catabasis Pharmaceuticals, Inc.
10.1.6 Forward Pharma A/S
10.1.7 Ixchel Pharma LLC
10.1.8 Pfizer Inc
10.1.9 ProQR Therapeutics NV
10.1.10 RaNA Therapeutics Inc
10.1.11 Reata Pharmaceuticals Inc
10.1.12 Retrotope Inc
10.1.13 Shire Plc
10.1.14 STATegics Inc
10.1.15 Voyager Therapeutics Inc
10.2 Friedreich Ataxia Drug Sales Date of Major Players (2017-2020e)
10.2.1 Adverum Biotechnologies Inc
10.2.2 BioMarin Pharmaceutical Inc.
10.2.3 Biovista Inc.
10.2.4 Cardero Therapeutics Inc
10.2.5 Catabasis Pharmaceuticals, Inc.
10.2.6 Forward Pharma A/S
10.2.7 Ixchel Pharma LLC
10.2.8 Pfizer Inc
10.2.9 ProQR Therapeutics NV
10.2.10 RaNA Therapeutics Inc
10.2.11 Reata Pharmaceuticals Inc
10.2.12 Retrotope Inc
10.2.13 Shire Plc
10.2.14 STATegics Inc
10.2.15 Voyager Therapeutics Inc
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
1.Table Friedreich Ataxia Drug Product Type Overview
2.Table Friedreich Ataxia Drug Product Type Market Share List
3.Table Friedreich Ataxia Drug Product Type of Major Players
4.Table Brief Introduction of Adverum Biotechnologies Inc
5.Table Brief Introduction of BioMarin Pharmaceutical Inc.
6.Table Brief Introduction of Biovista Inc.
7.Table Brief Introduction of Cardero Therapeutics Inc
8.Table Brief Introduction of Catabasis Pharmaceuticals, Inc.
9.Table Brief Introduction of Forward Pharma A/S
10.Table Brief Introduction of Ixchel Pharma LLC
11.Table Brief Introduction of Pfizer Inc
12.Table Brief Introduction of ProQR Therapeutics NV
13.Table Brief Introduction of RaNA Therapeutics Inc
14.Table Brief Introduction of Reata Pharmaceuticals Inc
15.Table Brief Introduction of Retrotope Inc
16.Table Brief Introduction of Shire Plc
17.Table Brief Introduction of STATegics Inc
18.Table Brief Introduction of Voyager Therapeutics Inc
19.Table Products & Services of Adverum Biotechnologies Inc
20.Table Products & Services of BioMarin Pharmaceutical Inc.
21.Table Products & Services of Biovista Inc.
22.Table Products & Services of Cardero Therapeutics Inc
23.Table Products & Services of Catabasis Pharmaceuticals, Inc.
24.Table Products & Services of Forward Pharma A/S
25.Table Products & Services of Ixchel Pharma LLC
26.Table Products & Services of Pfizer Inc
27.Table Products & Services of ProQR Therapeutics NV
28.Table Products & Services of RaNA Therapeutics Inc
29.Table Products & Services of Reata Pharmaceuticals Inc
30.Table Products & Services of Retrotope Inc
31.Table Products & Services of Shire Plc
32.Table Products & Services of STATegics Inc
33.Table Products & Services of Voyager Therapeutics Inc
34.Table Market Distribution of Major Players
35.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
36.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
37.Table Global Friedreich Ataxia Drug Market Forecast (Million USD) by Region 2021f-2026f
38.Table Global Friedreich Ataxia Drug Market Forecast (Million USD) Share by Region 2021f-2026f
39.Table Global Friedreich Ataxia Drug Market Forecast (Million USD) by Demand 2021f-2026f
40.Table Global Friedreich Ataxia Drug Market Forecast (Million USD) Share by Demand 2021f-2026f